These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. Buckner CM; Luers AJ; Calderon TM; Eugenin EA; Berman JW J Neuroimmune Pharmacol; 2006 Jun; 1(2):160-81. PubMed ID: 18040782 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders. Gendelman HE J Neuroimmune Pharmacol; 2007 Mar; 2(1):8-13. PubMed ID: 18040820 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers for neuroAIDS: the widening scope of metabolomics. Pendyala G; Want EJ; Webb W; Siuzdak G; Fox HS J Neuroimmune Pharmacol; 2007 Mar; 2(1):72-80. PubMed ID: 18040828 [TBL] [Abstract][Full Text] [Related]
9. Proceedings from the NIMH symposium on "NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV". Buch S; Chivero ET; Hoare J; Jumare J; Nakasujja N; Mudenda V; Paul R; Kanmogne GD; Sacktor N; Wood C; Royal W; Joseph J J Neurovirol; 2016 Oct; 22(5):699-702. PubMed ID: 27473196 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 and its causal relationship to immunosuppression and nervous system disease in AIDS: a review. Sotrel A; Dal Canto MC Hum Pathol; 2000 Oct; 31(10):1274-98. PubMed ID: 11070121 [TBL] [Abstract][Full Text] [Related]
12. Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. May S; Letendre S; Haubrich R; McCutchan JA; Heaton R; Capparelli E; Ellis R J Neuroimmune Pharmacol; 2007 Mar; 2(1):97-104. PubMed ID: 18040832 [TBL] [Abstract][Full Text] [Related]
14. A historical perspective on the University of Nebraska Medical Center's College of Dentistry Class of 1961. Willis MS; Badakhsh RA J Dent Educ; 2006 Jun; 70(6):667-75. PubMed ID: 16741135 [TBL] [Abstract][Full Text] [Related]
15. NeuroAIDS in West Africa: a full circle. Power C Can J Neurol Sci; 2007 May; 34(2):118-9. PubMed ID: 17598586 [No Abstract] [Full Text] [Related]
16. Global NeuroAIDS roundtable. Joseph J; Achim CL; Boivin MJ; Brew BJ; Clifford DB; Colosi DA; Ellis RJ; Heaton RK; Gallo-Diop A; Grant I; Kanmogne GD; Kumar M; Letendre S; Marcotte TD; Nath A; Pardo CA; Paul RH; Pulliam L; Robertson K; Royal W; Sacktor N; Sithinamsuwan P; Smith DM; Valcour V; Wigdahl B; Wood C J Neurovirol; 2013 Feb; 19(1):1-9. PubMed ID: 23354550 [TBL] [Abstract][Full Text] [Related]
17. Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS. Sagar V; Pilakka-Kanthikeel S; Martinez PC; Atluri VSR; Nair M PLoS One; 2017; 12(8):e0181642. PubMed ID: 28792504 [TBL] [Abstract][Full Text] [Related]
18. A preliminary report on the neuropsychologic sequelae of human immunodeficiency virus. Lunn S; Skydsbjerg M; Schulsinger H; Parnas J; Pedersen C; Mathiesen L Arch Gen Psychiatry; 1991 Feb; 48(2):139-42. PubMed ID: 1671200 [TBL] [Abstract][Full Text] [Related]
19. Non-human primate models of SIV infection and CNS neuropathology. Williams K; Lackner A; Mallard J Curr Opin Virol; 2016 Aug; 19():92-8. PubMed ID: 27544476 [TBL] [Abstract][Full Text] [Related]
20. Second assessment of NeuroAIDS in Africa. Robertson K; Kopnisky K; Hakim J; Merry C; Nakasujja N; Hall C; Traore M; Sacktor N; Clifford D; Newton C; Van Rie A; Holding P; Clements J; Zink C; Mielk J; Hosseinipour M; Lalloo U; AMod F; Marra C; Evans S; Liner J; J Neurovirol; 2008 Apr; 14(2):87-101. PubMed ID: 18370346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]